US NCI initiates Phase II enrollment for Reolysin -
Oncolytics Biotech completes dose escalation in Reolysin-docetaxel trial -
Oncolytics Biotech to initiate Phase II cancer combination therapy trial -
ONCY: Begins Ph 2 Trial of REOLYSIN(R) w/Paclitaxel and Carboplatin -
Oncolytics Biotech Inc. to Present at BIO 2008 International Convention -
ONCOLYTICS BIOTECH STARTS ENROLLMENT IN PHASE I/II OVARIAN CANCER TRIAL -
ONCOLYTICS BIOTECH STARTS ENROLLMENT IN PHASE I/II REOLYSIN TRIAL -
ONCY: Begins Ph I/II Trial of REOLYSIN(R) -
Oncolytics initiates enrollment for Phase II cancer trial -
ONCY: Begins Enrollment for Ph II Trial of REOLYSIN(R) w/PaclitaxelCarboplatin -
Oncolytics presents positive interim results from Phase II sarcoma study -
ONCY: Presents Interim Ph II Results re REOLYSIN(R) at ASCO -
Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting -
Oncolytics wins Canadian patent -